SAN FRANCISCO--(BUSINESS WIRE)--Encellin, a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D), announced the closing of a $9.9M financing ...

A Finnish team used a one-step method for polydimethylsiloxane encapsulated perovskite solar cells that simultaneously provide anti-reflective light management and shielding from oxygen and ...

Encellin Inc. has announced the closing of a US$9.9 million financing round that will support the company’s development of its cell encapsulation platform with an initial focus on type 1 diabetes.

In 2020, there were 2.3 million women diagnosed with breast cancer. Deaths related to cancer occur due to metastasis. In most types of solid tumors, spreading happens through collective migration, ...

LAS VEGAS, Dec. 16, 2025 /CNW/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes and ...